SAN FRANCISCO–(BUSINESS WIRE)–JMP Group LLC (NYSE: JMP), an investment banking and alternative asset
management firm, announced today that David Schechner has joined JMP
Securities as a managing director in its healthcare investment banking
group. Based in the firm’s Boston office, Mr. Schechner will focus on
the biotechnology, pharmaceutical and specialty pharmaceutical
industries.
“David is an excellent addition to our healthcare franchise,” said
Carter Mack, president of JMP Group. “With more than 25 years of Wall
Street experience, he has built and managed several respected life
sciences investment banking practices. He understands not only the
capital markets dynamics specific to life sciences companies but also
the M&A environment for them. We are confident that David will be a key
contributor to JMP Securities’ continuing success in the healthcare
sector.”
Mr. Schechner joins JMP Securities from Robert W. Baird & Co., where he
led biotechnology, pharmaceutical, and pharmaceutical services
investment banking since 2012. He was previously head of the
pharmaceuticals investment banking group at Canaccord Genuity, after
founding and leading the biotechnology investment banking group at
Needham & Company. Mr. Schechner also held senior investment banking
roles at Goldman Sachs and Bear Stearns, focusing on healthcare and
technology. He holds an MBA from Harvard Business School and a BA from
Cornell University.
About JMP Group
JMP Group LLC is a diversified capital markets firm that provides
investment banking, equity research, and sales and trading services to
corporate and institutional clients as well as alternative asset
management products and services to institutional and high-net-worth
investors. JMP Group conducts its investment banking and research, sales
and trading activities through JMP Securities; its hedge fund, venture
and private capital, and credit management activities through Harvest
Capital Strategies and JMP Asset Management; and the management of
Harvest Capital Credit Corporation (NASDAQ: HCAP), a business
development company, through HCAP Advisors. For more information, visit www.jmpg.com.
Contacts
Investor Relations Contact
JMP Group LLC
Andrew Palmer
(415) 835-8978
apalmer@jmpg.com
Media Relations Contacts
Dukas Linden Public Relations, Inc.
Zach Leibowitz
(646) 722-6528
zach@dlpr.com
Alyssa Noud
(646) 722-6525
alyssa@dlpr.com